IVBH is the world’s first technology-enabled platform designed to scale diagnostic development, enabling rapid and efficient growth from concept to commercialization. Operating at the intersection of artificial intelligence, transcriptomics and liquid biopsy, we are applying the most advanced tech to the most fundamental language of the human cell to bring the most accurate, affordable and accessible blood tests to market, for all of humanity, at scale. Our mission? To unlock the quality-of-life preservation that exists at stage zero. Our vision? To create the next century’s worth of impact on human health.

Unlocking the quality-of-life preservation that exists at the earliest stages of diseases that affect lung health, starting with lung cancer.

Unlocking the quality-of-life preservation that exists at the earliest stages of diseases that affect metabolic health, starting with metabolic dysfunction-associated steatotic liver disease (MASLD).

Unlocking the quality-of-life preservation that exists at the earliest stages of diseases that affect women’s health, starting with breast cancer.